NASDAQ ยท Healthcare ยท Drug Manufacturers - General
Market Cap
$31.89B
SectorHealthcare
IndustryDrug Manufacturers - General
52-Week Low$121.05
52-Week High$218.06
CEOChristopher A. Viehbacher
IPO DateSep 17, 1991
Employees7,605
CountryUnited States
Biogen Inc. is a leading biotechnology firm dedicated to the discovery, development, production, and distribution of treatments for complex neurological and neurodegenerative conditions. Its established portfolio includes a range of medications addressing multiple sclerosis (MS), such as TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA.